Morgan Stanley reiterated their overweight rating on shares of LifeStance Health Group (NASDAQ:LFST – Free Report) in a research report released on Monday morning, Benzinga reports. They currently have a $10.00 target price on the stock. Several other research analysts also recently weighed in on LFST. Jefferies Financial Group upped their target price on shares […]
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) insider Danish J. Qureshi sold 12,965 shares of the company’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $5.93, for a total transaction of $76,882.45. Following the completion of the transaction, the insider now owns […]
LifeStance Health Group (NASDAQ:LFST – Get Free Report) is set to release its 12/31/2023 earnings data before the market opens on Wednesday, February 28th. Analysts expect LifeStance Health Group to post earnings of ($0.09) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this […]
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 22,660,000 shares, an increase of 15.0% from the December 31st total of 19,700,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the […]
LifeStance Health Group (NASDAQ:LFST – Free Report) had its price target decreased by The Goldman Sachs Group from $9.00 to $8.00 in a research note issued to investors on Wednesday, Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock. Separately, JPMorgan Chase & Co. lowered their price target on shares […]